What question did this study set out to answer?

The research examines the relationship between inhaler type selection and its effects on CO2 emissions and healthcare costs in COPD management.

February 26, 2026

Carbon dioxide equivalent emissions and cost impact of non-clinically driven inhaler initiation or switch for COPD.

Key Points

The research examines the relationship between inhaler type selection and its effects on CO2 emissions and healthcare costs in COPD management.
Comparative analysis of CO2 emissions from dry powder inhalers (DPIs) and pressurized metered-dose inhalers (pMDIs)
Evaluation of healthcare resource utilization based on inhaler choice
Assessment of clinical outcomes related to inhaler switching or initiation
Non-clinically driven DPI use leads to CO2e emission savings, but also results in poorer clinical control.
Increased emissions offset any savings from DPI use, due to higher healthcare utilization.
Emissions from pMDIs with NGP are comparable to DPIs, warranting a reevaluation of prescribing guidelines.

Abstract

CO2e emission savings with non-clinically driven DPI use within the SITT class are offset by increased emissions from poorer clinical control and healthcare use. Prescribing policies/guidelines preferring DPIs over pMDIs for environmental reasons should be updated, recognizing that pMDIs with NGP have a greenhouse gas footprint similar to DPIs. Optimal COPD management through evidence-based guidelines and appropriate inhaler selection is crucial to minimizing carbon footprint and healthcare resource utilization while improving patient outcomes.

Bookmark

Cite This Study

Parsekar et al. (Mon,) studied this question.

synapsesocial.com/papers/699fe37b95ddcd3a253e75be https://doi.org/https://doi.org/10.1080/03007995.2026.2628120

Bookmark